Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001724416 | SCV002062416 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | TRIM63: BP4, BS1 |
Breakthrough Genomics, |
RCV001724416 | SCV005264075 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001703282 | SCV001929562 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724416 | SCV001957591 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001724416 | SCV001970068 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003948683 | SCV004759856 | benign | TRIM63-related disorder | 2019-10-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |